Trial intelligence / Profile preview

PRP vs HA for Knee Osteoarthritis with Synovitis

NCT03167333Unknown

Sponsor
Taipei Veterans General Hospital
Start
Mar 2020
Primary completion
Mar 2020
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Randomised trial of autologous platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoints: Visual Analog Scale at 12 weeks and Western Ontario and McMaster Universities Osteoarthritis Index at 12 weeks. Status: unknown.

02

Drugs

autologous platelet-rich plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03167333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03167333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call